Edwards Lifesciences EW Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $46.17B.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's market capitalization?
- Edwards Lifesciences (EW) reported market capitalization of $46.17B in Q1 2026.
- How has Edwards Lifesciences's market capitalization changed year-over-year?
- Edwards Lifesciences's market capitalization increased by 8.7% year-over-year, from $42.46B to $46.17B.
- What is the long-term trend for Edwards Lifesciences's market capitalization?
- Over 4 years (2021 to 2025), Edwards Lifesciences's market capitalization has grown at a -9.2% compound annual growth rate (CAGR), from $268.45B to $182.08B.
- What does market capitalization mean?
- What the stock market says the company's equity is worth.
- How do you interpret market capitalization?
- A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
- How does market capitalization compare across companies?
- Comparable across companies as a size class; the input to every equity-price valuation multiple.